BMP Pharma Trading AG (STU:BMP) Debt-to-Equity: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BMP BMP Pharma Trading AG STU:BMP
36 GF Score
Price €7.50
! 4 Warning Signs
View Full Analysis

What is BMP Pharma Trading AG Debt-to-Equity?

BMP Pharma Trading AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €0.00 Mil. BMP Pharma Trading AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €0.00 Mil. BMP Pharma Trading AG's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BMP Pharma Trading AG's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of BMP Pharma Trading AG was 0.10. The lowest was 0.01. And the median was 0.04.

STU:BMP's Debt-to-Equity is not ranked *
in the Medical Distribution industry.
Industry Median: 0.465
* Ranked among companies with meaningful Debt-to-Equity only.

BMP Pharma Trading AG  (STU:BMP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BMP Pharma Trading AG Debt-to-Equity Related Terms

BMP Pharma Trading AG Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for BMP Pharma Trading AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BMP Pharma Trading AG Debt-to-Equity Chart

BMP Pharma Trading AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.04 0.03 0.01 0.00

BMP Pharma Trading AG Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.01 N/A 0.00 N/A

STU:BMP vs MCK, COR, CAH: Debt-to-Equity Comparison

For the Medical Distribution subindustry, BMP Pharma Trading AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BMP Pharma Trading AG Debt-to-Equity vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BMP Pharma Trading AG's Debt-to-Equity falls into.


STU:BMP
36GF Score
BMP Pharma Trading AG STU:BMP
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BMP Pharma Trading AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BMP Pharma Trading AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 8.896
=0.00

BMP Pharma Trading AG's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BMP Pharma Trading AG Business Description

Address Bornbarch 16, Norderstedt, SH, DEU, 22848
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score

Get the complete analysis for STU:BMP

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.50
Price